MMA.inc (纽交所美国版: MMA) 已与Precision Peptide (加拿大证券交易所: BPC) 签署了一项独家合作协议,双方将建立一种创新的50/50收益共享伙伴关系,共同专注于多肽领域的发展。这一战略联盟旨在结合双方的专业优势,探索和开发多肽相关产品与市场机会,并约定将由此产生的收入进行对半平分。此举标志着两家公司在生物技术,特别是多肽这一细分赛道上深化了合作,以期共同开拓市场并实现增长。
MMA.inc (纽交所美国版: MMA) 已与Precision Peptide (加拿大证券交易所: BPC) 签署了一项独家合作协议,双方将建立一种创新的50/50收益共享伙伴关系,共同专注于多肽领域的发展。这一战略联盟旨在结合双方的专业优势,探索和开发多肽相关产品与市场机会,并约定将由此产生的收入进行对半平分。此举标志着两家公司在生物技术,特别是多肽这一细分赛道上深化了合作,以期共同开拓市场并实现增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.